InPoint Commercial Real Estate Income, Inc. — FY2023 Form 10-K
Reporting period: Year ended December 31, 2023. Financial amounts below are in millions unless stated otherwise; the filing generally reports dollar amounts in thousands. This is an annual report, not a standalone fourth-quarter report.
Business context
InPoint is an externally managed REIT focused primarily on commercial real estate debt, especially floating-rate first-mortgage loans, with some subordinate loans and other real estate-related investments. It had no employees and relied on affiliated advisors. Its common stock has no public trading market.
Financial performance and position
| Metric | FY2023 / Dec. 31, 2023 | FY2022 / Dec. 31, 2022 |
|---|---|---|
| Total income | $38.8 million | $38.0 million |
| Interest income / expense | $68.3 million / $42.2 million | $44.6 million / $21.4 million |
| Net interest income | $26.1 million | $23.3 million |
| Net income (loss) attributable to common stockholders | $(10.4) million; $(1.03) per share | $4.4 million; $0.42 per share |
| Provision for credit losses | $16.9 million | $3.6 million |
| Operating cash flow | $16.2 million | $18.5 million |
| Cash and cash equivalents | $54.1 million | $29.4 million |
| Commercial mortgage loans, net of credit-loss allowance | $722.0 million | $842.3 million |
| Repurchase agreements / credit facility / loan participations sold | $457.4 million / $9.5 million / $57.2 million | $488.1 million / $18.4 million / $99.4 million |
| Total assets / liabilities / GAAP stockholders’ equity | $780.3 million / $529.8 million / $250.6 million | $914.5 million / $635.9 million / $278.6 million |
| Common-stock NAV | $171.0 million; $16.8995 per share | Not provided in the supplied text |
Weighted-average loan yield was 8.1%, up from 7.8%; weighted-average borrowing cost rose to 7.4% from 3.8%, compressing the net interest spread. The average leverage measure reported by the Company was 248.7%, compared with 237.0% in 2022. These measures use the Company’s stated definitions and should not be treated as directly comparable to other issuers’ metrics.
Common distributions declared were $1.25 per share for 2023, and the Company reported that 100% were funded from operating cash flow. It paid $12.5 million in common distributions and $6.0 million in preferred dividends. The 6.75% Series A preferred stock is listed on the NYSE; its liquidation preference is $25 per share.
Material changes versus 2022
- Common-stock results shifted from $4.4 million of income to a $10.4 million loss, driven principally by the higher credit-loss provision and the hotel impairment.
- The loan portfolio fell about 14%: six loans were paid off, repayments were $107.5 million, and no new loans were originated. The portfolio had 36 loans at year-end versus 43 in 2022.
- The CECL allowance for credit losses increased to $21.8 million on loans, from $3.6 million. Adoption of the CECL standard on January 1, 2023 reduced opening equity by $5.1 million, including reserves related to unfunded commitments.
- The Company sold the Renaissance Chicago O’Hare hotel in September for net proceeds of $11.9 million. A $6.9 million impairment was recorded before sale, followed by a $0.2 million sale gain; the combined impact was a $6.7 million loss. The sale also ended the related ground-lease obligation.
- Cash increased by $24.7 million, principally as loan repayments and the property sale generated investing cash, while financing cash outflows included debt repayments and distributions.
Outlook, risks and unusual items
- Operating plans: Management said it expected to continue prioritizing liquidity and anticipated no new loan originations at least through the first half of 2024, with several loans nearing maturity. The Federal Reserve’s rate path and refinancing conditions remain important to borrowers and the Company’s funding costs. No quantified earnings or distribution guidance was provided.
- Strategic alternatives and liquidity: The Board is evaluating strategic alternatives with assistance from Robert A. Stanger & Co.; the filing gives no assurance that a transaction or other alternative will result. The primary common offering, share repurchase plan (SRP) and distribution reinvestment plan (DRP) were suspended in early 2023 and remained suspended as described in the filing. Common shares are not exchange-listed, limiting stockholder liquidity.
- Credit and refinancing risk: Two loans were on nonaccrual at December 31, 2023, with $43.2 million of outstanding balances and $7.1 million of asset-specific CECL reserves in total. A separate office loan was placed on nonaccrual in February 2024. Several loans had matured or were approaching maturity; some extensions and repayments depended on borrower refinancing or property sales.
- Financing and covenants: The Company relies on floating-rate, collateralized financing. At year-end, its JPM facility balance was $457.4 million and its Western Alliance credit facility balance was $9.5 million. Western Alliance waived a debt-service-coverage covenant after the reported ratio was 1.47 against a 1.50 minimum; JPM had previously waived its covenant for year-end 2022. The Company reported covenant compliance at year-end 2023.
- Distributions: The Board may change or suspend distributions. The filing warns that distributions may not be covered by future operating cash flow and that past distributions have at times been funded from sources other than operations. 2023 distributions were reported as fully covered by that year’s operating cash flow.
- Valuation and conflicts: NAV is an estimated, unaudited measure, and most loans are carried at amortized cost subject to impairment testing. The advisor calculates NAV and receives fees linked in part to portfolio value; the Company also discloses conflicts related to affiliated management and allocation of investments.
- Other: Management reported no material pending or known contemplated legal proceedings and no material cybersecurity incident through the filing date. KPMG issued an unqualified opinion on the financial statements; management concluded internal control over financial reporting was effective, but the auditor was not engaged to attest to that conclusion.
Important facts for investors to verify
- Current status of the strategic-alternatives review, primary offering, SRP and DRP, and any implications for common-stock liquidity.
- Performance, collateral values, extensions and eventual repayment or recovery of the nonaccrual and near-maturity loans; also assess the adequacy and sensitivity of CECL reserves.
- Availability and terms of secured financing, collateral and liquidity requirements, and compliance with facility covenants, including any further waivers.
- Whether the $1.25 annual common distribution remains supportable from recurring operating cash flow, particularly given the 2023 loss and preferred dividend obligation.
- How reported NAV compares with realizable value, including the valuation approach for illiquid loans and the absence of a public trading market.
- Key post-year-end developments: the filing reports common distributions declared in January and February 2024 and a preferred dividend of $0.421875 per share declared in February.